Prophylactic and Therapeutic Potential of Asp f1 Epitopes in Naïve and Sensitized BALB/c Mice

키워드

참고문헌 (56)

1. Tillie-Leblond I, "Allergic bronchopulmonary aspergillosis", Allergy, 60, pp.1004~1013 (2005)
2. Stevens DA, "Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference", Clin Infect Dis, 37, pp.S225~S264 (2003)
3. Zander DS, "Allergic bronchopulmonary aspergillosis: an overview", Arch Pathol Lab Med, 129, pp.924~928 (2005)
4. Eaton T, "Allergic bronchopulmonary aspergillosis in the asthma clinic in A prospective evaluation of CT in the diagnostic algorithm", Chest, 118, pp.66~72 (2000)
5. Larche M, "Immunological mechanisms of allergen-specific immunotherapy", Nat Rev Immunol, 6, pp.761~771 (2006)
6. Akdis M, "Mechanisms of allergen-specific immunotherapy", J Allergy Clin Immunol, 119, pp.780~791 (2007)
7. Ajduk J, "Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children", Ann Allergy Asthma Immunol, 100, pp.314~323 (2008)
8. Pfaar O, "Anaphylaxis--life-threatening allergic reactions", MMW Fortschr Med, 150, pp.35~39 (2008)
9. Pfaar O, "Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation:a double-blind, placebo-controlled trial", Ann Allergy Asthma Immunol, 100, pp.256~263 (2008)
10. Senti G, "Efficacy and safety of allergen-specific immunotherapy in rhinitis, rhinoconjunctivitis, and bee", wasp venom allergies, 2005, pp.24, 519~531
11. Akdis CA, "Mechanisms and treatment of allergic disease in the big picture of regulatory T cells", J Allergy Clin Immunol, 123, pp.735~746 (2009)
12. Lizaso MT, "Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters", Pediatr Allergy Immunol, 19, pp.76~81 (2008)
13. Malling HJ, "Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium", Allergy, 43, pp.60~70 (1988)
14. Tabar AI, "Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety", Pediatr Allergy Immunol, 19, pp.67~75 (2008)
15. Chauhan B, "T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis", J Clin Invest, 97, pp.2324~2331 (1996)
16. Kurup VP, "Immunodominant peptide epitopes of allergen, Asp f1 from the fungus Aspergillus fumigatus", Peptides, 19, pp.1469~1477 (1998)
17. Madan T, "Ribonuclease activity dependent cytotoxicity of Asp fl, a major allergen of A.fumigatus", Mol Cell Biochem, 175, pp.21~27 (1997)
18. Madan T, "Identification and evaluation of a major cytotoxin of A in fumigatus", Mol Cell Biochem, 167, pp.89~97 (1997)
19. Madan T, "Use of a synthetic peptide epitope of Asp f1, a major allergen or antigen of Aspergillus fumigatus,for improved immunodiagnosis of allergic bronchopulmonary aspergillosis", Clin Diagn Lab Immunol, 11, pp.552~558 (2004)
20. Ramadan G, "Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen", Clin Exp Immunol, 140, pp.81~91 (2005)
21. Ramadan G, "Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen", Clin Exp Immunol, 139, pp.257~267 (2005)
22. Svirshchevskaya EV, "Determination of T and B Cell Epitopes of Aspergillus fumigatus Ribotoxin and Heat Shock Protein", Russ J Immunol, 3, pp.61~68 (1998)
23. Arruda LK, "Selective expression of a major allergen and cytotoxin, Asp f I, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus-related diseases", J Immunol, 149, pp.3354~3359 (1992)
24. Moser M, "Cloning and expression of recombinant Aspergillus fumigatus allergen I", a (rAsp f I, J Immunol, pp.1992, 149[DOI]
25. Kamal N, "Tryptophan residue is essential for immunoreactivity of a diagnostically relevant peptide epitope of A in fumigatus", Mol Cell Biochem, 275, pp.223~231 (2005)
26. Svirshchevskaya E, "Intravenous injection of major and cryptic peptide epitopes of ribotoxin, Asp f1 inhibits T cell response induced by crude Aspergillus fumigatus antigens in mice", Peptides, 21, pp.1~8 (2000)
27. Bhasin M, "SVM based method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence", Bioinformatics, 20, pp.421~423 (2004)
28. Zhang GL, "a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB", c mouse, 2005, pp.33, W180~W183
29. Bhasin M, "Prediction of CTL epitopes using QM, SVM and ANN techniques", Vaccine, 22, pp.3195~3204 (2004)
30. Madan T, "Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens", J Clin Invest, 107, pp.467~475 (2001)
31. Astori M, "Inducing tolerance by intranasal administration of long peptides in naive and primed CBA", J mice, 2000, pp.165, 3497~3505
32. Hall G, "Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production", Vaccine, 21, pp.549~561 (2003)
33. Nigam S, "Altered immune response to liposomal allergens of Aspergillus fumigatus in mice", Int J Pharm, 236, pp.97~109 (2002)
34. Boyum A, "Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g", Scand J Clin Lab Invest Suppl, 97, pp.77~89 (1968)
35. Alexander C, "Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+;CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects", Clin Exp Allergy, 35, pp.52~58 (2005)
36. Hoyne GF, "Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice", J Exp Med, 178, pp.1783~1788 (1993)
37. Kay AB, "Allergen immunotherapy with cat allergen peptides", Springer Semin Immunopathol, 25, pp.391~399 (2004)
38. Yoshitomi T, "Intraoral administration of a T-cell epitope peptide induces immunological tolerance in Cry j 2-sensitized mice", J Pept Sci, 13, pp.499~503 (2007)
39. Helbling A, "Immunotherapy in fungal allergy", Curr Allergy Asthma Rep, 3, pp.447~453 (2003)
40. Crameri R, "Fungal allergies: a yet unsolved problem", Chem Immunol Allergy, 91, pp.121~133 (2006)
41. Simon-Nobbe B, "The spectrum of fungal allergy", Int Arch Allergy Immunol, 145, pp.58~86 (2008)
42. Finkelman FD, "IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses", J Immunol, 140, pp.1022~1027 (1988)
43. Kozutsumi D, "Cry-consensus peptide, a novel peptide for immunotherapy of Japanese cedar pollinosis, induces Th1-predominant response in Cry j 1-sensitized B10.S mice", Biol Pharm Bull, 29, pp.2506~2509 (2006)
44. von Garnier C, "Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis", Eur J Immunol, 30, pp.1638~1645 (2000)
45. Furin MJ, "Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity", J Allergy Clin Immunol, 88, pp.27~32 (1991)
46. Rak S, "The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients", J Allergy Clin Immunol, 82, pp.470~480 (1988)
47. Hamelmann E, "Role of the Th2 cytokines in the development of allergen-induced airway inflammation and hyperresponsiveness", Int Arch Allergy Immunol, 118, pp.90~94 (1999)
48. Kurup VP, "Anti-interleukin (IL)-4 and -IL-5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens", Allergy, 52, pp.1215~1221 (1997)
49. Romani L, "Immunity to fungal infections", Nat Rev Immunol, 4, pp.1~23 (2004)
50. Bettelli E, "IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together", J Exp Med, 201, pp.167~171 (2005)
51. Jutel M, "Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression", Int Arch Allergy Immunol, 124, pp.190~192 (2001)
52. Jutel M, "Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors", Nature, 413, pp.420~ (2001), 425
53. Johansen P, "Medication with antihistamines impairs allergen-specific immunotherapy in mice", Clin Exp Allergy, 38, pp.512~519 (2008)
54. Jutel M, "Histamine receptors in immune regulation and allergen-specific immunotherapy", Immunol Allergy Clin North Am, 26, pp.245~259 (2006)
55. Mehra NK, "Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population", Hum Immunol, 32, pp.246~253 (1991)
56. Texier C, "HLA-DR restricted peptide candidates for bee venom immunotherapy", J Immunol, 164, pp.3177~3184 (2000)

관련 논문AI추천